Title: Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study
Authors: Becker, Richard C ×
Moliterno, David J
Jennings, Lisa K
Pieper, Karen S
Pei, Jinglan
Niederman, Alan
Ziada, Khaled M
Berman, Gail
Strony, John
Joseph, Diane
Mahaffey, Kenneth W
Van de Werf, Frans
Veltri, Enrico
Harrington, Robert A #
Issue Date: Mar-2009
Publisher: Elsevier science inc
Series Title: Lancet vol:373 issue:9667 pages:919-928
Abstract: Background An antithrombotic drug is needed that safely reduces cardiovascular events in patients undergoing percutaneous coronary intervention (PCI). We therefore assessed the tolerability and safety of SCH 530348-an oral platelet protease-activated receptor-1 antagonist.
ISSN: 0140-6736
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Cardiology
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science